Cadiz Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.25 Cr
- Paid Up Capital ₹ 1.82 Cr
- Company Age 14 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 56.00 Cr
- Revenue Growth %
- Profit Growth -210.42%
- Ebitda -237.87%
- Net Worth -10.53%
- Total Assets -10.88%
About Cadiz Pharmaceuticals
Cadiz Pharmaceuticals Private Limited (CPPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 September 2010 and has a history of 14 years and four months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.25 Cr and a paid-up capital of Rs 1.82 Cr.
The company has closed loans amounting to ₹56.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Zubair Ahmad and Neeraj Agarwal serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999DL2010PTC208371
-
Company No.
208371
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
16 Sep 2010
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Cadiz Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Zubair Ahmad
|
Director | 16-Sep-2010 | Current |
|
Neeraj Agarwal
|
Director | 18-Oct-2010 | Current |
Financial Performance of Cadiz Pharmaceuticals.
Cadiz Pharmaceuticals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 210.42% decrease in profit. The company's net worth observed a substantial decline by a decrease of 10.53%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cadiz Pharmaceuticals?
In 2023, Cadiz Pharmaceuticals had a promoter holding of 47.58% and a public holding of 52.42%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Ashley Pharmatech Private LimitedNeeraj Agarwal is a mutual person
-
Riya Apparels Private LimitedZubair Ahmad is a mutual person
-
Dee Pharma Private Limited
Zubair Ahmad is a mutual person
-
Panacea Orgichem Private Limited
Neeraj Agarwal is a mutual person
-
Elder Orgichem Private Limited
Neeraj Agarwal is a mutual person
Charges (Loans)
₹0
₹56.00 Cr
Charges Breakdown by Lending Institutions
- Others : 22.50 Cr
- Dena Bank : 19.00 Cr
- Punjab National Bank : 9.50 Cr
- Canara Bank : 5.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Oct 2017 | Others | ₹22.50 Cr | Satisfied |
| 12 Feb 2014 | Dena Bank | ₹19.00 Cr | Satisfied |
| 20 Mar 2012 | Punjab National Bank | ₹1.00 Cr | Satisfied |
| 18 Aug 2011 | Punjab National Bank | ₹8.50 Cr | Satisfied |
| 06 Jan 2011 | Canara Bank | ₹5.00 Cr | Satisfied |
How Many Employees Work at Cadiz Pharmaceuticals?
Unlock and access historical data on people associated with Cadiz Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cadiz Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cadiz Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
